Project Details
Description
PINK1 modulating drugs will do good to both cancer patients and patients with neurodegenerative disorders.
Status | Finished |
---|---|
Effective start/end date | 8/1/20 → 7/31/21 |
Keywords
- PINK1
- PD-L1
- Tumor microenvironment
- Metabolism
- Glycolysis
- Immunotherapy
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.